Search results
Found 60497 matches for
Paper published in Lancet Psychiatry may help with the accurate detection of this form of autoimmune encephalitis
Collaboration in Action: Chrystalina Antoniades
Strategic Developments
19 June 2024
Chrystalina Antoniades is an Associate Professor of Clinical Neuroscience at the Nuffield Department of Clinical Neurosciences. In her story, Chrystalina shares her experience of collaboration and her top tips for successfully working with industry - ensuring mutual alignment and showcasing your passion.
Congratulations to Linxin Li
Awards and Honours Research Highlights
27 March 2024
Who has been awarded a prestigious fellowship.
World Sleep Day
Events Public Engagement
15 March 2024
Friday the 15th March marked World Sleep Day. To celebrate, we put on some fascinating, interactive public engagement events.
New online tool for child anxiety could expand access to child mental health services
Research Highlights
7 February 2024
New research from the University of Oxford has revealed that an online programme that empowers parents to apply Cognitive Behavioural Therapy (CBT) principles in their child’s day to day lives is just as effective as traditional talking therapies for child anxiety problems.
Welcome Prof Shelley McKeown Jones
Research Highlights Strategic Developments
26 January 2024
Fellow and Tutor in Experimental Psychology with Lady Margaret Hall joining us from Bristol
Prestigious prize for Asifa Majid
Awards and Honours
26 January 2024
Our Professor of Cognitive Science, Asifa Majid, has been awarded the prestigious Elman prize
Professor Zoltán Molnár’s Einstein Visiting Fellowship at the Charité – Universitätsmedizin Berlin renewed
Awards and Honours
11 January 2024
Virtual Reality technology to treat agoraphobia approved
Research Highlights
30 November 2023
For the first time a virtual reality treatment (VR) has been recommended for use in NHS mental health services.
Farewell to the Le Gros Clark Building
Strategic Developments
29 November 2023
We say goodbye to a building that has been central through our development as DPAG
Launch of innovative new study to tackle mental health inequalities
Research Highlights Strategic Developments
29 November 2023
An innovative new study working with diverse people living with psychosis and other long-term physical health conditions.
Brain Health Innovation Summit
Events Strategic Developments
28 November 2023
Where expertise meets innovation:a taskforce driving brain health research
Preventive Neurology Public Engagement Day
Public Engagement
28 November 2023
Our team visited Templars Square shopping centre on Wednesday the 21st November 2023.
New survey reveals that a quarter of UK adults mistrust others
Research Highlights
24 November 2023
A major new survey of trust and mistrust in the UK has revealed that a quarter of respondents mistrustful of other people.
Taking a statin at the same time as an antidepressant leads to better treatment adherence
14 November 2023
New study by Oxford University shows that taking a statin at the same time as an antidepressant leads to better treatment adherence, which may be of importance to people with depression.
Professor Rebeccah Slater presented with Excellent Supervisor Award
Awards and Honours
8 November 2023
Rebeccah Slater, Professor of Paediatric Neuroscience, Senior Wellcome Fellow and Chair of the Department of Paediatrics’ Equality, Diversity and Inclusivity Committee, has been presented with the Excellent Supervisor Award by the Head of the Medical Sciences Division (MSD).
Finnish Ambassador visits NDCN
International
7 November 2023
NDCN hosted a networking event with a delegation from the Finnish embassy and a group of University of Oxford students from Finland.
Researchers use AI to build a map of how the human brain develops in the womb
Research Highlights
25 October 2023
Professor David M Clark joins Oxford Health as Non-Executive Director
Awards and Honours Strategic Developments
20 July 2023
The Emeritus Professor of Experimental Psychology took up his role on 17 July 2023.
University of Oxford and Selvita collaborate to advance potential therapeutics for Parkinson's Disease
Strategic Developments
1 June 2023
The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease